We refer to a recently published article 1 that shows a new Bayesian method, applied to assess a vaccination strategy preventing human papillomavirus (HPV)-related diseases. The article basically describes a model for the economic evaluation of the quadrivalent HPV vaccine in Italy, concluding that it is a costeffective strategy. Although any model, Bayesian or Frequentist, should be "populated" with reliable data, 2 we felt some concern about many "inputs" regarding the Italian setting that could weaken the authors' conclusions. We have listed some of the main ones.
More in general, the authors state that the cost-effectiveness of the quadrivalent vaccine is proven, ignoring the other, bivalent vaccine against HPV. As 3 recent critical reviews 10-12 on economic evaluations regarding HPV vaccines-not cited in the articleconcluded that long-term models on HPV vaccination lack transparency in key assumptions and methodological choices, we wonder whether the results of this model (producing a "virtual" follow-up of 90 y) can really be considered more reliable than the others already published. 
Transparency or Proper Study Valuation Procedures Missed?
To the Editor:
We wish to thank the Editor for giving us the opportunity to think about and resolve a few potential issues with our paper. Garattini and colleagues have questioned the meaningfulness of the evidence used to inform some of the crucial parameter used in our model. This is because of a misalignment in the reference list, as a result of which, Table 1 in the paper points to the wrong references. We have fixed this and present the corrected version of Table 1 below.
Incidentally, we notice that the online appendix to the paper 1 actually has all the correct references and describes in detail all the aspects of the modeling presented in the paper. We find it slightly bizarre that Garattini and colleagues have taken such a critical stance on our work, but have failed to cross-check the most technical aspects with all the available material.
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